PhenoAgeAccel was associated with breast cancer incidence in both the Sister Study and EPIC cohorts [24, 33], and DNAm estimators of circulating CD8+ T cells and monocytes appear to be time‐dependent markers of breast cancer risk [31]. This evidence concerns the gene CD8A and breast carcinoma.